These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6342912)

  • 1. Lung surfactant for replacement therapy.
    Robertson B
    Clin Physiol; 1983 Apr; 3(2):97-110. PubMed ID: 6342912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies: synthetic or natural surfactant. The case for natural surfactant.
    Halliday HL
    J Perinat Med; 1996; 24(5):417-26. PubMed ID: 8950721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of artificial surfactant (ALEC) in the prophylaxis of neonatal respiratory distress syndrome.
    Morley CJ
    Eur Respir J Suppl; 1989 Mar; 3():81s-86s. PubMed ID: 2663001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant replacement in the management of the neonatal respiratory distress syndrome.
    Robertson B
    Eur J Respir Dis Suppl; 1987; 153():242-8. PubMed ID: 3322864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll RF; Wiswell T
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial reconstituted pulmonary surfactant in prevention and treatment of respiratory distress syndrome in neonates.
    Jiang ZQ; Sun GM; Ma YM
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):182-4. PubMed ID: 10072978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential treatments of premature lambs with an artificial surfactant and natural surfactant.
    Ikegami M; Jobe A; Jacobs H; Jones SJ
    J Clin Invest; 1981 Aug; 68(2):491-6. PubMed ID: 6790576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys.
    Revak SD; Merritt TA; Cochrane CG; Heldt GP; Alberts MS; Anderson DW; Kheiter A
    Pediatr Res; 1996 Apr; 39(4 Pt 1):715-24. PubMed ID: 8848350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Substitutive therapy with surfactants in premature infants with respiratory distress syndrome].
    Liberatore A; Carrera G; Calciolari G; Coccia C; Coppalini B; Fulconis F; Moro G; Scimone F; Villa G; Minoli I
    Ann Osp Maria Vittoria Torino; 1987-1988; 30():28-35. PubMed ID: 3334194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome.
    Reynolds MS; Wallander KA
    Clin Pharm; 1989 Aug; 8(8):559-76. PubMed ID: 2670398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological activity of pulmonary surfactant with low protein content: effect of enrichment with synthetic phospholipids.
    Berggren P; Curstedt T; Grossman G; Nilsson R; Robertson B
    Exp Lung Res; 1985; 8(1):29-51. PubMed ID: 3846531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lucinactant for the treatment of respiratory distress syndrome in neonates.
    Piehl E; Fernandez-Bustamante A
    Drugs Today (Barc); 2012 Sep; 48(9):587-93. PubMed ID: 23032799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung surfactant in an era of replacement therapy.
    Notter RH; Shapiro DL
    Pediatrics; 1981 Dec; 68(6):781-9. PubMed ID: 6275335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural and artificial lung surfactant replacement therapy in premature lambs.
    Egan EA; Notter RH; Kwong MS; Shapiro DL
    J Appl Physiol Respir Environ Exerc Physiol; 1983 Sep; 55(3):875-83. PubMed ID: 6556192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.
    Walti H; Monset-Couchard M
    Drug Saf; 1998 May; 18(5):321-37. PubMed ID: 9589844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial surfactant in preterm rabbits with and without respiratory distress syndrome: difference of in vitro and in vivo activities.
    Obladen M; Kampmann W; Zimmermann I; Lachmann B
    Eur J Pediatr; 1985 Jul; 144(2):195-9. PubMed ID: 3850023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.